Pascale Ribaux

Dr. Pascale Ribaux

University Medical Center, Geneva, Genève, Switzerland
orcid

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2007 in Diabetes
Verified
Journal Article
Closed access
PDF file
JEJan A. Ehses
Jan A. Ehses
APAurel Perren
Aurel Perren
EEElisabeth Eppler
Elisabeth Eppler
PRPascale Ribaux
Pascale Ribaux
JPJohn A. Pospisilik
John A. Pospisilik
MDMarc Y. Donath
Marc Y. Donath
Activation of the innate immune system in obesity is a risk factor for the development of type 2 diabetes. The aim of the current study was to investigate the notion that increased numbers of macrophages exist in the islets of type 2 diabetes patients and that this may be explained by a dysregulation of islet-derived inflammatory factors. Increased islet-associated immune cells were observed in human type 2 diabetic patients, high-fat–fed C57BL/6J mice, the GK rat, and the db/db mouse. When cultured islets were exposed to a type 2 diabetic milieu or when islets were isolated from high-fat–fed mice, increased islet-derived inflammatory factors were produced and released, including interleukin (IL)-6, IL-8, chemokine KC, granulocyte colony-stimulating factor, and macrophage inflammatory protein 1α. The specificity of this response was investigated by direct comparison to nonislet pancreatic tissue and β-cell lines and was not mimicked by the induction of islet cell death. Further, this inflammatory response was found to be biologically functional, as conditioned medium from human islets exposed to a type 2 diabetic milieu could induce increased migration of monocytes and neutrophils. This migration was blocked by IL-8 neutralization, and IL-8 was localized to the human pancreatic α-cell. Therefore, islet-derived inflammatory factors are regulated by a type 2 diabetic milieu and may contribute to the macrophage infiltration of pancreatic islets that we observe in type 2 diabetes.

7 March 2016 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
XBXimena Bonilla
Ximena Bonilla
LPLaurent Parmentier
Laurent Parmentier
BKBryan King
Bryan King
FBFedor Bezrukov
Fedor Bezrukov
GKGürkan Kaya
Gürkan Kaya
SNSergey I Nikolaev
Sergey I Nikolaev

3 May 2019 in Science
Verified
Journal Article
Closed access
PDF file
ODO. Delaneau
O. Delaneau
MZM. Zazhytska
M. Zazhytska
CBC. Borel
C. Borel
GGG. Giannuzzi
G. Giannuzzi
GRGuillaume Rey
Guillaume Rey
EDE. T. Dermitzakis
E. T. Dermitzakis
Noncoding variation and gene expression: Natural genetic variation outside of protein coding regions affects multiple molecular phenotypes that can differ across individuals. To examine how genomic variation affects proximal (cis) or distal (trans) gene regulation, Delaneau et al. analyzed gene expression, chromatin, and the three-dimensional conformation of the genome. Clustering regulatory elements and activity across individuals reveals genomic structures termed cis-regulatory domains and trans-regulatory hubs that affect gene expression. Associations between these structures and genes within and across chromosomes contribute to links between noncoding genetic variation and gene expression. Science , this issue p. eaat8266

1 February 2009 in Cell Metabolism
Verified
Journal Article
Closed access
FSFabienne T. Schulthess
Fabienne T. Schulthess
FPFederico Paroni
Federico Paroni
NSNadine S. Sauter
Nadine S. Sauter
LSLuan Shu
Luan Shu
PRPascale Ribaux
Pascale Ribaux
KMKathrin Maedler
Kathrin Maedler

1 January 2015 in The American Journal of Human Genetics
Verified
Journal Article
Closed access
CBChristelle Borel
Christelle Borel
Pedro G. FerreiraPedro G. Ferreira
Pedro G. Ferreira
FSFederico Santoni
Federico Santoni
ODOlivier Delaneau
Olivier Delaneau
AFAlexandre Fort
Alexandre Fort
SAStylianos E. Antonarakis
Stylianos E. Antonarakis

3 December 2018 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
MGMarco Garieri
Marco Garieri
GSGeorgios Stamoulis
Georgios Stamoulis
XBXavier Blanc
Xavier Blanc
EFEmilie Falconnet
Emilie Falconnet
PRPascale Ribaux
Pascale Ribaux
SAStylianos E. Antonarakis
Stylianos E. Antonarakis
X-chromosome inactivation (XCI) provides a dosage compensation mechanism where, in each female cell, one of the two X chromosomes is randomly silenced. However, some genes on the inactive X chromosome and outside the pseudoautosomal regions escape from XCI and are expressed from both alleles (escapees). We investigated XCI at single-cell resolution combining deep single-cell RNA sequencing with whole-genome sequencing to examine allelic-specific expression in 935 primary fibroblast and 48 lymphoblastoid single cells from five female individuals. In this framework we integrated an original method to identify and exclude doublets of cells. In fibroblast cells, we have identified 55 genes as escapees including five undescribed escapee genes. Moreover, we observed that all genes exhibit a variable propensity to escape XCI in each cell and cell type and that each cell displays a distinct expression profile of the escapee genes. A metric, the Inactivation Score—defined as the mean of the allelic expression profiles of the escapees per cell—enables us to discover a heterogeneous and continuous degree of cellular XCI with extremes represented by “inactive” cells, i.e., cells exclusively expressing the escaping genes from the active X chromosome and “escaping” cells expressing the escapees from both alleles. We found that this effect is associated with cell-cycle phases and, independently, with the XIST expression level, which is higher in the quiescent phase (G0). Single-cell allele-specific expression is a powerful tool to identify novel escapees in different tissues and provide evidence of an unexpected cellular heterogeneity of XCI.